BRODOSI, LUCIA
 Distribuzione geografica
Continente #
AS - Asia 2.890
NA - Nord America 2.721
EU - Europa 1.800
AF - Africa 161
SA - Sud America 156
OC - Oceania 2
Totale 7.730
Nazione #
US - Stati Uniti d'America 2.676
SG - Singapore 1.030
CN - Cina 876
IT - Italia 391
GB - Regno Unito 306
DE - Germania 263
VN - Vietnam 252
SE - Svezia 247
HK - Hong Kong 238
IN - India 168
KR - Corea 155
NL - Olanda 117
BR - Brasile 108
FR - Francia 89
RU - Federazione Russa 86
IE - Irlanda 85
CI - Costa d'Avorio 43
SC - Seychelles 43
FI - Finlandia 36
BG - Bulgaria 35
JP - Giappone 32
ID - Indonesia 31
CA - Canada 29
NG - Nigeria 25
JO - Giordania 23
UA - Ucraina 23
AT - Austria 20
PL - Polonia 19
TG - Togo 19
AR - Argentina 18
CH - Svizzera 18
ZA - Sudafrica 18
BE - Belgio 15
GR - Grecia 15
TR - Turchia 14
MX - Messico 13
BD - Bangladesh 12
IR - Iran 11
MY - Malesia 11
EC - Ecuador 10
IQ - Iraq 10
EE - Estonia 9
ES - Italia 9
PK - Pakistan 9
EG - Egitto 7
CL - Cile 5
LT - Lituania 5
PE - Perù 5
RO - Romania 5
LB - Libano 3
PY - Paraguay 3
TW - Taiwan 3
AU - Australia 2
AZ - Azerbaigian 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
MA - Marocco 2
NO - Norvegia 2
RS - Serbia 2
SA - Arabia Saudita 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
HN - Honduras 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 7.730
Città #
Singapore 704
Ashburn 418
Hefei 342
Southend 240
Hong Kong 237
Chandler 233
Santa Clara 176
Seoul 151
Fairfield 150
Dallas 125
Beijing 100
Bologna 97
Princeton 97
Seattle 88
Boardman 86
Dublin 85
Houston 76
Woodbridge 76
Dong Ket 63
Los Angeles 60
Wilmington 59
Redmond 53
Hanoi 49
Ann Arbor 48
Cambridge 45
Abidjan 43
Ho Chi Minh City 43
Bengaluru 38
Milan 34
Sofia 34
Munich 33
New York 31
Redondo Beach 31
Tokyo 31
Abeokuta 25
Des Moines 24
Rome 24
Amman 23
Medford 23
Berlin 22
Buffalo 22
Helsinki 22
San Diego 22
Turin 22
Frankfurt am Main 20
Guangzhou 19
Lomé 19
Westminster 17
Jakarta 16
Brussels 15
São Paulo 15
London 14
Shanghai 14
Council Bluffs 13
Falkenstein 13
Padova 13
Amsterdam 12
Düsseldorf 12
Jinan 12
Parma 12
Tongling 12
Warsaw 12
Lappeenranta 11
Vienna 11
Chicago 10
Hyderabad 10
Kuala Lumpur 10
Montreal 10
Nanjing 10
Zhengzhou 10
Bern 9
Brooklyn 9
Florence 9
Jacksonville 9
Nuremberg 9
Saint Petersburg 9
Bremen 8
Ankara 7
Cesena 7
Dhaka 7
Karbala 7
Naples 7
Phoenix 7
Atlanta 6
Baar 6
Castel Maggiore 6
Haiphong 6
Hove 6
Mexico City 6
Nanchang 6
Norwalk 6
Paris 6
Poplar 6
Portsmouth 6
San Francisco 6
San Jose 6
Toronto 6
Wuhan 6
Yubileyny 6
Zola Predosa 6
Totale 4.953
Nome #
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 203
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 196
Liver Stiffness measurments using Fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients. 191
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report. 180
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers 175
Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential 167
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. 164
Long-term weight loss maintenance for obesity: A multidisciplinary approach 163
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 151
Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update 149
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting 148
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 148
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease 148
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs 145
Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant) 143
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 141
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 140
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 139
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink? 138
CD 133+ stem cells for the treatment of end stage liver disease. 137
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 131
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study 128
Fatty liver in pregnancy: a narrative review of two distinct conditions 128
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 125
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. 125
Maternal PKU: Defining phenylalanine tolerance and its variation during pregnancy, according to genetic background 123
Pegvaliase therapy for phenylketonuria: Real-world case series and clinical insights 122
Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction 120
Dati preliminari sullo studio della sintomatologia ortoressica tra pazienti diabetici affetti da epatopatia. 119
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey 116
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 114
Management of non-alcoholic fatty liver disease 110
The treatment of diabetes in advanced liver disease: change of a paradigm 108
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 108
Malnutrition in hospitalized patients with SARS-CoV-2 infection 107
Obesity and NAFLD: Same problem? 107
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity 106
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis. 106
Bone marrow derived stem cells for the treatment of end-stage liver disease. 104
COMBINATION study: COMbined Behavioural/INcretin Action sTudy In Obese/diabetic persoNs 97
A cross-sectional study on the prevalence of eating disorders in liver transplanted patients with type 2 diabetes and/or overweight/obesity 96
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 96
Capitolo 14 "Epatiti Virali Croniche", Volume IX "Malattie del Fegato, delle Vie Biliari e del Pancreas", Trattato di Medicina Interna, fondato da Paolo Larizza 94
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 93
CD133+ stem cells for the treatment of end-stage liver disease 92
Psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects 90
NASH: A glance at the landscape of pharmacological treatment 89
Effect of physical exercise on postural control in diabetic subjects 89
Undiagnosed Phenylketonuria Can Exist Everywhere: Results From an International Survey 87
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 86
CD133+ hematopoietic stem cells reinfusion in end-stage liver disease (ESLD): final results of a phase I clinical trial 86
Web-based counseling for NAFLD. Final results. 81
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease 80
The management of transitional care of patients affected by phenylketonuria in Italy: Review and expert opinion 77
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients 76
Reinfusion of highly purified CD133+ stem cells in patients with end-stage liver disease (ESLD): final results of a phase I clinical trial 68
'Effect of exercise training on postural control in people with diabetes 67
Management of patients with phenylketonuria (PKU) under enzyme replacement therapy: An Italian model (expert opinion) 66
A modified Child-Turcotte-Pugh (CTP) for selection of candidates to liver transplantation (LT) with low model for end-stage liver disease score (MELD). 60
Increased survival after sustained virological response in liver transplanted patients with HCV recurrence: taking-up a challenge for the hepatologist. 59
Increased survival after sustained virological response in liver transplanted patients with HCV recurrence: taking-up a challenge for the hepatologist. 58
A modified Child-Turcotte-Pugh (CTP) for selection of patients affected by cirrhosis candidates for liver transplantation (LT) with low model for end-stage liver disease score (MELD) 58
NEUROD1 mutation in an Italian patient with maturity onset diabetes of the young 6: a case report 58
Hepatitis C recurrence after liver transplantation: do patients with mild disease need to be treated? 56
Exercise-induced changes in postural stability among patients with diabetes 51
Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes 51
Benefits of a prolonged-release amino acid mixture in four pregnant women with phenylketonuria 50
NAFLD, the hepatic manifestation of the metabolic syndrome 50
Seven score systems to evaluate candidates to orthotopic liver transplantation: which is the winner? 46
Natremia and Child-Turcotte-Pugh (CTP) score may improve the selection of candidates for liver transplantation (LT) with lower model for end-stage liver disease score (MELD) 43
Natremia and Child-Turcotte-Pugh (CTP) may improve the selection of candidates for liver transplantation (LT) with lower model for end-stage liver disease score (MELD). 42
Impact of exercise training on postural control in people with diabetes. 41
Motor control evaluation in diabetic subjects 41
Effect of six months of exercise program on eye movements of diabetic people. 37
The role of physical activity on autonomic functions in diabetic patients 33
Effects of physical exercise on autonomic control in diabetic patients. 29
Impact of exercise protocol on postural control in people with diabetes 25
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders 15
Relationship Between Physical Activity and Autonomic Responses in Adults with Type 2 Diabetes 14
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders 12
null 1
Totale 7.913
Categoria #
all - tutte 25.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021258 0 0 0 0 0 60 0 26 42 20 5 105
2021/2022943 52 117 48 57 81 38 18 56 40 64 238 134
2022/20231.011 85 116 56 127 86 106 40 33 203 30 65 64
2023/2024463 42 69 33 43 35 83 14 48 18 39 13 26
2024/20251.966 77 230 172 190 254 71 117 74 52 151 146 432
2025/20262.571 446 499 483 466 483 194 0 0 0 0 0 0
Totale 7.913